Patrick J Grohar

12PUBLICATIONS
95CO-AUTHORS
Molecular targetsBiologically active moleculesPredictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Apr 16, 2026
Trabectedin and low-dose irinotecan to target EWS::FLI1 in Ewing sarcoma: a phase 1/2 trial.

|Feb 16, 2026
Mithramycin alters EWS::FLI1 DNA binding and RNA polymerase II processivity to inhibit nascent transcription.

Rebecca Kaufman, Guillermo Flores, Elissa A Boguslawski

|Nov 03, 2025
Molecular Characterization Informs Prognosis in Patients With Localized Ewing Sarcoma: A Report From the Children's Oncology Group.

Riaz Gillani, David S Shulman, Natalie J DelRocco

|Sep 05, 2025
Advancing Preclinical Biology for Ewing Sarcoma: An International Effort.

Filemon S Dela Cruz, Elizabeth A Stewart, Didier Surdez

|Feb 20, 2025
Molecular characterization informs prognosis in patients with localized Ewing sarcoma: A report from the Children's Oncology Group.

Riaz Gillani, David S Shulman, Natalie J DelRocco

|Mar 20, 2024
Cell Context Is the Third Axis of Synergy for the Combination of ATR Inhibition and Cisplatin in Ewing Sarcoma.

Jennifer Jess, Katie M Sorensen, Elissa A Boguslawski

Pageof 2

Frequent Collaborators

6 joint publications

Damon Reed

5 joint publications

Kelly M Bailey

5 joint publications

Brian D Crompton

4 joint publications

Elissa A Boguslawski